The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis

Sara E Meyer1, Glendon M Zinser, William D Stuart

  • 1Department of Cancer and Cell Biology, Vontz Center for Molecular Studies, University of Cincinnati College of Medicine, 3125 Eden Ave, Cincinnati, OH 45267-0521, USA.

Insights

The Ron receptor tyrosine kinase negatively regulates mammary gland development. Ablating its tyrosine kinase domain accelerates pubertal development, increasing ductal branching through MAPK signaling.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Oncology

Background:

  • The Ron receptor tyrosine kinase (RTK) is present in normal breast tissue.
  • RTK is overexpressed in about 50% of human breast cancers.
  • The role of Ron in normal mammary gland development is unknown.

Purpose of the Study:

  • To investigate the functional significance of Ron in normal mammary gland development.
  • To compare mammary gland development in wild-type mice and mice with targeted ablation of the Ron tyrosine kinase (TK) signaling domain (TK-/-).

Main Methods:

  • Comparison of mammary gland development in wild-type and RonTK-/- mice.
  • Analysis of epithelial cell turnover, circulating hormone levels, and MAPK phosphorylation.
  • Ex vivo culture of purified epithelial cells and MAPK inhibition.
  • Microarray analysis of pubertal mammary glands.

Main Results:

  • RonTK-/- mice exhibited accelerated pubertal development with increased ductal extension and branching morphogenesis.
  • Increased MAPK phosphorylation in the epithelium correlated with enhanced branching.
  • Ex vivo RonTK-/- epithelial cells showed enhanced branching, which was attenuated by MAPK inhibition.
  • Microarray analysis identified 393 genes temporally affected by Ron expression, impacting development, morphogenesis, differentiation, cell motility, and adhesion signaling networks.

Conclusions:

  • The Ron receptor tyrosine kinase acts as a critical negative regulator of mammary gland development.
  • Ron signaling influences ductal morphogenesis and branching through MAPK pathways.
  • These findings provide new insights into the molecular mechanisms governing normal breast development and potential therapeutic targets in breast cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...